Improving physical activity in COPD: towards a new paradigm

Thierry Troosters, Thys van der Molen, Michael Polkey, Roberto A Rabinovich, Ioannis Vogiatzis, Idelle Weisman, Karoly Kulich, Thierry Troosters, Thys van der Molen, Michael Polkey, Roberto A Rabinovich, Ioannis Vogiatzis, Idelle Weisman, Karoly Kulich

Abstract

Chronic obstructive pulmonary disease (COPD) is a debilitating disease affecting patients in daily life, both physically and emotionally. Symptoms such as dyspnea and muscle fatigue, lead to exercise intolerance, which, together with behavioral issues, trigger physical inactivity, a key feature of COPD. Physical inactivity is associated with adverse clinical outcomes, including hospitalization and all-cause mortality. Increasing activity levels is crucial for effective management strategies and could lead to improved long-term outcomes. In this review we summarize objective and subjective instruments for evaluating physical activity and focus on interventions such as pulmonary rehabilitation or bronchodilators aimed at increasing activity levels. To date, only limited evidence exists to support the effectiveness of these interventions. We suggest that a multimodal approach comprising pulmonary rehabilitation, pharmacotherapy, and counselling programs aimed at addressing emotional and behavioural aspects of COPD may be an effective way to increase physical activity and improve health status in the long term.

Figures

Figure 1
Figure 1
The vicious cycle of inactivity and symptoms.
Figure 2
Figure 2
Regular physical activity reduces hospital admissions (upper panel A) and all-cause death (lower panel B) [50]. Kaplan-Meier curves according to level of regular physical activity during follow-up. Patients with COPD from the Copenhagen City Heart Study (n=2386), recruited from 1981 and followed to 2000. Reproduced from [50] with permission from BMJ Publishing Group Ltd.
Figure 3
Figure 3
Change in morning activities (absolute scores) over treatment period with budesonide/formoterol plus tiotropium versus placebo plus tiotropium [74]. CDLM: Capacity of Daily Living during the Morning questionnaire; dotted line represents budesonide/formoterol plus tiotropium; solid line represents placebo plus tiotropium; CDLM score at run-in budesonide/formoterol plus tiotropium: 4.09, placebo plus tiotropium: 4.13; †treatment comparison from randomization to first week of treatment; ‡treatment comparison from randomization to last week of treatment. Reprinted with permission of the American Thoracic Society. Copyright © 2013 American Thoracic Society. Welte T, Miravitlles M, Hernandez P, Eriksson G, Peterson S, Polanowski T, et al: Efficacy and tolerability of budesonide/formoterol added to tiotropium in patients withchronic obstructive pulmonary disease. Am J Respir Crit Care Med 2009, 180:741–750. Official journal of the American Thoracic Society.

References

    1. Cooper CB. Airflow obstruction and exercise. Respir Med. 2009;103:325–334. doi: 10.1016/j.rmed.2008.10.026.
    1. Global Initiative for Obstructive Lung Disease. Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease. 2013. .
    1. Polkey MI, Moxham J. Attacking the disease spiral in chronic obstructive pulmonary disease. Clin Med. 2006;6:190–196. doi: 10.7861/clinmedicine.6-2-190.
    1. Arne M, Lundin F, Boman G, Janson C, Janson S, Emtner M. Factors associated with good self-rated health and quality of life in subjects with self-reported COPD. Int J Chron Obstruct Pulmon Dis. 2011;6:511–519.
    1. Pitta F, Troosters T, Spruit MA, Probst VS, Decramer M, Gosselink R. Characteristics of physical activities in daily life in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2005;171:972–977. doi: 10.1164/rccm.200407-855OC.
    1. Vorrink SN, Kort HS, Troosters T, Lammers JW. Level of daily physical activity in individuals with COPD compared with healthy controls. Respir Res. 2011;12:33. doi: 10.1186/1465-9921-12-33.
    1. Shrikrishna D, Patel M, Tanner RJ, Seymour JM, Connolly BA, Puthucheary ZA. et al.Quadriceps wasting and physical inactivity in patients with COPD. Eur Respir J. 2012;40:1115–1122. doi: 10.1183/09031936.00170111.
    1. Troosters T, Sciurba F, Battaglia S, Langer D, Valluri SR, Martino L. et al.Physical inactivity in patients with COPD, a controlled multi-center pilot-study. Respir Med. 2010;104:1005–1011. doi: 10.1016/j.rmed.2010.01.012.
    1. Watz H, Waschki B, Meyer T, Magnussen H. Physical activity in patients with COPD. Eur Respir J. 2009;33:262–272.
    1. Garcia-Aymerich J, Serra I, Gomez FP, Farrero E, Balcells E, Rodriguez DA. et al.Physical activity and clinical and functional status in COPD. Chest. 2009;136:62–70. doi: 10.1378/chest.08-2532.
    1. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA. et al.Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346:393–403.
    1. World Health Organization. Global recommendation on physical activity for health. .
    1. Nici L, Donner C, Wouters E, Zuwallack R, Ambrosino N, Bourbeau J. et al.American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation. Am J Respir Crit Care Med. 2006;173:1390–1413. doi: 10.1164/rccm.200508-1211ST.
    1. Arne M, Janson C, Janson S, Boman G, Lindqvist U, Berne C. et al.Physical activity and quality of life in subjects with chronic disease: chronic obstructive pulmonary disease compared with rheumatoid arthritis and diabetes mellitus. Scand J Prim Health Care. 2009;27:141–147. doi: 10.1080/02813430902808643.
    1. Caspersen CJ, Powell KE, Christenson GM. Physical activity, exercise, and physical fitness: definitions and distinctions for health-related research. Public Health Rep. 1985;100:126–131.
    1. Pitta F, Troosters T, Probst VS, Spruit MA, Decramer M, Gosselink R. Quantifying physical activity in daily life with questionnaires and motion sensors in COPD. Eur Respir J. 2006;27:1040–1055. doi: 10.1183/09031936.06.00064105.
    1. Schutz Y, Weinsier RL, Hunter GR. Assessment of free-living physical activity in humans: an overview of currently available and proposed new measures. Obes Res. 2001;9:368–379. doi: 10.1038/oby.2001.48.
    1. Baarends EM, Schols AM, Pannemans DL, Westerterp KR, Wouters EF. Total free living energy expenditure in patients with severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1997;155:549–554. doi: 10.1164/ajrccm.155.2.9032193.
    1. Hartman JE, Boezen HM, de Greef MH, Bossenbroek L, ten Hacken NH. Consequences of physical inactivity in chronic obstructive pulmonary disease. Expert Rev Respir Med. 2010;4:735–745. doi: 10.1586/ers.10.76.
    1. Kocks JW, Kerstjens HA, Snijders SL, De VB, Biermann JJ, Van HP. et al.Health status in routine clinical practice: validity of the clinical COPD questionnaire at the individual patient level. Health Qual Life Outcomes. 2010;8:135. doi: 10.1186/1477-7525-8-135.
    1. Lichtman SW, Pisarska K, Berman ER, Pestone M, Dowling H, Offenbacher E. et al.Discrepancy between self-reported and actual caloric intake and exercise in obese subjects. N Engl J Med. 1992;327:1893–1898. doi: 10.1056/NEJM199212313272701.
    1. Washburn RA, Heath GW, Jackson AW. Reliability and validity issues concerning large-scale surveillance of physical activity. Res Q Exerc Sport. 2000;71:S104–S113.
    1. Sarkin JA, Nichols JF, Sallis JF, Calfas KJ. Self-report measures and scoring protocols affect prevalence estimates of meeting physical activity guidelines. Med Sci Sports Exerc. 2000;32:149–156.
    1. Shephard RJ. Assessment of physical activity and energy needs. Am J Clin Nutr. 1989;50:1195–1200.
    1. Pitta F, Troosters T, Spruit MA, Decramer M, Gosselink R. Activity monitoring for assessment of physical activities in daily life in patients with chronic obstructive pulmonary disease. Arch Phys Med Rehabil. 2005;86:1979–1985. doi: 10.1016/j.apmr.2005.04.016.
    1. Taylor HL, Jacobs DR Jr, Schucker B, Knudsen J, Leon AS, Debacker G. A questionnaire for the assessment of leisure time physical activities. J Chronic Dis. 1978;31:741–755. doi: 10.1016/0021-9681(78)90058-9.
    1. Baecke JA, Burema J, Frijters JE. A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am J Clin Nutr. 1982;36:936–942.
    1. Voorrips LE, Ravelli AC, Dongelmans PC, Deurenberg P, Van Staveren WA. A physical activity questionnaire for the elderly. Med Sci Sports Exerc. 1991;23:974–979.
    1. Follick MJ, Ahern DK, Laser-Wolston N. Evaluation of a daily activity diary for chronic pain patients. Pain. 1984;19:373–382. doi: 10.1016/0304-3959(84)90083-6.
    1. Washburn RA, Smith KW, Jette AM, Janney CA. The Physical Activity Scale for the Elderly (PASE): development and evaluation. J Clin Epidemiol. 1993;46:153–162. doi: 10.1016/0895-4356(93)90053-4.
    1. Washburn RA, McAuley E, Katula J, Mihalko SL, Boileau RA. The physical activity scale for the elderly (PASE): evidence for validity. J Clin Epidemiol. 1999;52:643–651. doi: 10.1016/S0895-4356(99)00049-9.
    1. Caspersen CJ, Bloemberg BP, Saris WH, Merritt RK, Kromhout D. The prevalence of selected physical activities and their relation with coronary heart disease risk factors in elderly men: the Zutphen Study, 1985. Am J Epidemiol. 1991;133:1078–1092.
    1. Garfield BE, Canavan JL, Smith CJ, Ingram KA, Fowler RP, Clark AL. et al.Stanford Seven-Day Physical Activity Recall questionnaire in COPD. Eur Respir J. 2012;40:356–362. doi: 10.1183/09031936.00113611.
    1. Scheers T, Philippaerts R, Lefevre J. Assessment of physical activity and inactivity in multiple domains of daily life: a comparison between a computerized questionnaire and the SenseWear Armband complemented with an electronic diary. Int J Behav Nutr Phys Act. 2012;9:71. doi: 10.1186/1479-5868-9-71.
    1. Van RH, Giavedoni S, Raste Y, Burtin C, Louvaris Z, Gimeno-Santos E. et al.Validity of activity monitors in health and chronic disease: a systematic review. Int J Behav Nutr Phys Act. 2012;9:84. doi: 10.1186/1479-5868-9-84.
    1. Cyarto EV, Myers A, Tudor-Locke C. Pedometer accuracy in nursing home and community-dwelling older adults. Med Sci Sports Exerc. 2004;36:205–209. doi: 10.1249/01.MSS.0000113476.62469.98.
    1. Benzo R. Activity monitoring in chronic obstructive pulmonary disease. J Cardiopulm Rehabil Prev. 2009;29:341–347. doi: 10.1097/HCR.0b013e3181be7a3c.
    1. de Blok BM, de Greef MH, ten Hacken NH, Sprenger SR, Postema K, Wempe JB. The effects of a lifestyle physical activity counseling program with feedback of a pedometer during pulmonary rehabilitation in patients with COPD: a pilot study. Patient Educ Couns. 2006;61:48–55. doi: 10.1016/j.pec.2005.02.005.
    1. Hospes G. Bossenbroek L, ten Hacken NH, van HP, de Greef MH: Enhancement of daily physical activity increases physical fitness of outclinic COPD patients: results of an exercise counseling program. Patient Educ Couns. 2009;75:274–278. doi: 10.1016/j.pec.2008.10.005.
    1. Schonhofer B, Ardes P, Geibel M, Kohler D, Jones PW. Evaluation of a movement detector to measure daily activity in patients with chronic lung disease. Eur Respir J. 1997;10:2814–2819. doi: 10.1183/09031936.97.10122814.
    1. Glaab T, Vogelmeier C, Buhl R. Outcome measures in chronic obstructive pulmonary disease (COPD): strengths and limitations. Respir Res. 2010;11:79. doi: 10.1186/1465-9921-11-79.
    1. Fensli R, Pedersen PE, Gundersen T, Hejlesen O. Sensor acceptance model - measuring patient acceptance of wearable sensors. Methods Inf Med. 2008;47:89–95.
    1. Casaburi R. Activity monitoring in assessing activities of daily living. COPD. 2007;4:251–255. doi: 10.1080/15412550701480158.
    1. Waschki B, Spruit MA, Watz H, Albert PS, Shrikrishna D, Groenen M. et al.Physical activity monitoring in COPD: compliance and associations with clinical characteristics in a multicenter study. Respir Med. 2012;106:522–530. doi: 10.1016/j.rmed.2011.10.022.
    1. Van RH, Raste Y, Louvaris Z, Giavedoni S, Burtin C, Langer D. et al.Validity of six activity monitors in chronic obstructive pulmonary disease: a comparison with indirect calorimetry. PLoS One. 2012;7:e39198. doi: 10.1371/journal.pone.0039198.
    1. Rabinovich RA, Louvaris Z, Raste Y, Langer D, Remoortel HV, Giavedoni S, Validity of physical activity monitors during daily life in patients with COPD. Eur Respir J. 2013. Epub ahead of print.
    1. Matthews CE, Hagstromer M, Pober DM, Bowles HR. Best practices for using physical activity monitors in population-based research. Med Sci Sports Exerc. 2012;44:S68–S76.
    1. Garcia-Rio F, Rojo B, Casitas R, Lores V, Madero R, Romero D. et al.Prognostic value of the objective measurement of daily physical activity in patients with COPD. Chest. 2012;142:338–346. doi: 10.1378/chest.11-2014.
    1. Waschki B, Kirsten A, Holz O, Muller KC, Meyer T, Watz H. et al.Physical activity is the strongest predictor of all-cause mortality in patients with COPD: a prospective cohort study. Chest. 2011;140:331–342. doi: 10.1378/chest.10-2521.
    1. Garcia-Aymerich J, Lange P, Benet M, Schnohr P, Anto JM. Regular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease: a population based cohort study. Thorax. 2006;61:772–778. doi: 10.1136/thx.2006.060145.
    1. Bahadori K, FitzGerald JM. Risk factors of hospitalization and readmission of patients with COPD exacerbation–systematic review. Int J Chron Obstruct Pulmon Dis. 2007;2:241–251.
    1. Pitta F, Troosters T, Probst VS, Spruit MA, Decramer M, Gosselink R. Physical activity and hospitalization for exacerbation of COPD. Chest. 2006;129:536–544. doi: 10.1378/chest.129.3.536.
    1. Esteban C, Quintana JM, Aburto M, Moraza J, Egurrola M, Perez-Izquierdo J. et al.Impact of changes in physical activity on health-related quality of life among patients with COPD. Eur Respir J. 2010;36:292–300. doi: 10.1183/09031936.00021409.
    1. Lacasse Y, Martin S, Lasserson TJ, Goldstein RS. Meta-analysis of respiratory rehabilitation in chronic obstructive pulmonary disease. A Cochrane systematic review. Eura Medicophys. 2007;43:475–485.
    1. Troosters T, Casaburi R, Gosselink R, Decramer M. Pulmonary rehabilitation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2005;172:19–38. doi: 10.1164/rccm.200408-1109SO.
    1. Williams V, Bruton A, Ellis-Hill C, McPherson K. The effect of pulmonary rehabilitation on perceptions of breathlessness and activity in COPD patients: a qualitative study. Prim Care Respir J. 2010;19:45–51. doi: 10.4104/pcrj.2009.00044.
    1. Coronado M, Janssens JP, De MB, Terrier P, Schutz Y, Fitting JW. Walking activity measured by accelerometry during respiratory rehabilitation. J Cardiopulm Rehabil. 2003;23:357–364. doi: 10.1097/00008483-200309000-00006.
    1. Dallas MI, McCusker C, Haggerty MC, Rochester CL, Zuwallack R. Using pedometers to monitor walking activity in outcome assessment for pulmonary rehabilitation. Chron Respir Dis. 2009;6:217–224.
    1. Steele BG, Belza B, Hunziker J, Holt L, Legro M, Coppersmith J. et al.Monitoring daily activity during pulmonary rehabilitation using a triaxial accelerometer. J Cardiopulm Rehabil. 2003;23:139–142. doi: 10.1097/00008483-200303000-00011.
    1. Mercken EM, Hageman GJ, Schols AM, Akkermans MA, Bast A, Wouters EF. Rehabilitation decreases exercise-induced oxidative stress in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2005;172:994–1001. doi: 10.1164/rccm.200411-1580OC.
    1. Sewell L, Singh SJ, Williams JE, Collier R, Morgan MD. Can individualized rehabilitation improve functional independence in elderly patients with COPD? Chest. 2005;128:1194–1200. doi: 10.1378/chest.128.3.1194.
    1. Walker PP, Burnett A, Flavahan PW, Calverley PM. Lower limb activity and its determinants in COPD. Thorax. 2008;63:683–689. doi: 10.1136/thx.2007.087130.
    1. Cindy Ng LW, Mackney J, Jenkins S, Hill K. Does exercise training change physical activity in people with COPD? A systematic review and meta-analysis. Chron Respir Dis. 2012;9:17–26. doi: 10.1177/1479972311430335.
    1. Bauman AE, Reis RS, Sallis JF, Wells JC, Loos RJ, Martin BW. Correlates of physical activity: why are some people physically active and others not? Lancet. 2012;380:258–271. doi: 10.1016/S0140-6736(12)60735-1.
    1. Polkey MI, Rabe KF. Chicken or egg: physical activity in COPD revisited. Eur Respir J. 2009;33:227–229.
    1. Ringbaek T, Brondum E, Martinez G, Lange P. Rehabilitation in COPD: the long-term effect of a supervised 7-week program succeeded by a self-monitored walking program. Chron Respir Dis. 2008;5:75–80. doi: 10.1177/1479972307087366.
    1. Moy ML, Weston NA, Wilson EJ, Hess ML, Richardson CR. A pilot study of an Internet walking program and pedometer in COPD. Respir Med. 2012;106:1342–1350. doi: 10.1016/j.rmed.2012.06.013.
    1. Garcia-Rio F, Lores V, Mediano O, Rojo B, Hernanz A, Lopez-Collazo E. et al.Daily physical activity in patients with chronic obstructive pulmonary disease is mainly associated with dynamic hyperinflation. Am J Respir Crit Care Med. 2009;180:506–512. doi: 10.1164/rccm.200812-1873OC.
    1. Lahaije AJ, van Helvoort HA, Dekhuijzen PN, Heijdra YF. Physiologic limitations during daily life activities in COPD patients. Respir Med. 2010;104:1152–1159. doi: 10.1016/j.rmed.2010.02.011.
    1. O'Donnell DE, Laveneziana P, Ora J, Webb KA, Lam YM, Ofir D. Evaluation of acute bronchodilator reversibility in patients with symptoms of GOLD stage I COPD. Thorax. 2009;64:216–223. doi: 10.1136/thx.2008.103598.
    1. Casaburi R, Kukafka D, Cooper CB, Witek TJ Jr, Kesten S. Improvement in exercise tolerance with the combination of tiotropium and pulmonary rehabilitation in patients with COPD. Chest. 2005;127:809–817. doi: 10.1378/chest.127.3.809.
    1. Troosters T, Celli B, Lystig T, Kesten S, Mehra S, Tashkin DP. et al.Tiotropium as a first maintenance drug in COPD: secondary analysis of the UPLIFT trial. Eur Respir J. 2010;36:65–73. doi: 10.1183/09031936.00127809.
    1. Kesten S, Casaburi R, Kukafka D, Cooper CB. Improvement in self-reported exercise participation with the combination of tiotropium and rehabilitative exercise training in COPD patients. Int J Chron Obstruct Pulmon Dis. 2008;3:127–136.
    1. Welte T, Miravitlles M, Hernandez P, Eriksson G, Peterson S, Polanowski T. et al.Efficacy and tolerability of budesonide/formoterol added to tiotropium in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2009;180:741–750. doi: 10.1164/rccm.200904-0492OC.
    1. Partridge MR, Karlsson N, Small IR. Patient insight into the impact of chronic obstructive pulmonary disease in the morning: an internet survey. Curr Med Res Opin. 2009;25:2043–2048. doi: 10.1185/03007990903103006.
    1. Global Initiative for Obstructive Lung Disease. Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease. 2010. .
    1. Troosters T, Weisman I, Dobbels F, Giardino N, Valluri SR. Assessing the Impact of Tiotropium on Lung Function and Physical Activity in GOLD Stage II COPD Patients who are Naive to Maintenance Respiratory Therapy: A Study Protocol. Open Respir Med J. 2011;5:1–9. doi: 10.2174/1874306401105010001.
    1. Pitta F, Troosters T, Probst VS, Langer D, Decramer M, Gosselink R. Are patients with COPD more active after pulmonary rehabilitation? Chest. 2008;134:273–280. doi: 10.1378/chest.07-2655.
    1. Berry MJ, Rejeski WJ, Adair NE, Zaccaro D. Exercise rehabilitation and chronic obstructive pulmonary disease stage. Am J Respir Crit Care Med. 1999;160:1248–1253. doi: 10.1164/ajrccm.160.4.9901014.
    1. Clark CJ, Cochrane LM, Mackay E, Paton B. Skeletal muscle strength and endurance in patients with mild COPD and the effects of weight training. Eur Respir J. 2000;15:92–97. doi: 10.1183/09031936.00.15109200.
    1. Lacasse Y, Goldstein R, Lasserson TJ, Martin S. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2006;4:CD003793.
    1. Rossi G, Florini F, Romagnoli M, Bellantone T, Lucic S, Lugli D. et al.Length and clinical effectiveness of pulmonary rehabilitation in outpatients with chronic airway obstruction. Chest. 2005;127:105–109. doi: 10.1378/chest.127.1.105.
    1. O'Donnell DE, Sciurba F, Celli B, Mahler DA, Webb KA, Kalberg CJ. et al.Effect of fluticasone propionate/salmeterol on lung hyperinflation and exercise endurance in COPD. Chest. 2006;130:647–656. doi: 10.1378/chest.130.3.647.
    1. O'Donnell DE, Fluge T, Gerken F, Hamilton A, Webb K, Aguilaniu B. et al.Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD. Eur Respir J. 2004;23:832–840. doi: 10.1183/09031936.04.00116004.
    1. Stav D, Raz M. Effect of N-acetylcysteine on air trapping in COPD: a randomized placebo-controlled study. Chest. 2009;136:381–386. doi: 10.1378/chest.09-0421.
    1. Hataji O, Naito M, Ito K, Watanabe F, Gabazza EC, Taguchi O. Indacaterol improves daily physical activity in patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2013;8:1–5.
    1. O'Donnell DE, Casaburi R, Vincken W, Puente-Maestu L, Swales J, Lawrence D. et al.Effect of indacaterol on exercise endurance and lung hyperinflation in COPD. Respir Med. 2011;105:1030–1036. doi: 10.1016/j.rmed.2011.03.014.
    1. Behnke M, Wewel AR, Kirsten D, Jorres RA, Magnussen H. Exercise training raises daily activity stronger than predicted from exercise capacity in patients with COPD. Respir Med. 2005;99:711–717. doi: 10.1016/j.rmed.2004.10.016.
    1. Breyer MK, Breyer-Kohansal R, Funk GC, Dornhofer N, Spruit MA, Wouters EF. et al.Nordic walking improves daily physical activities in COPD: a randomised controlled trial. Respir Res. 2010;11:112. doi: 10.1186/1465-9921-11-112.
    1. Mador MJ, Patel AN, Nadler J. Effects of pulmonary rehabilitation on activity levels in patients with chronic obstructive pulmonary disease. J Cardiopulm Rehabil Prev. 2011;31:52–59. doi: 10.1097/HCR.0b013e3181ebf2ef.
    1. Probst VS, Kovelis D, Hernandes NA, Camillo CA, Cavalheri V, Pitta F. Effects of 2 exercise training programs on physical activity in daily life in patients with COPD. Respir Care. 2011;56:1799–1807. doi: 10.4187/respcare.01110.
    1. der PJ V, Van DV, Effing T, Zielhuis G, Kerstjens H. Community based physiotherapeutic exercise in COPD self-management: a randomised controlled trial. Respir Med. 2011;105:418–426. doi: 10.1016/j.rmed.2010.09.017.
    1. Watz H, Waschki B, Boehme C, Claussen M, Meyer T, Magnussen H. Extrapulmonary effects of chronic obstructive pulmonary disease on physical activity: a cross-sectional study. Am J Respir Crit Care Med. 2008;177:743–751. doi: 10.1164/rccm.200707-1011OC.

Source: PubMed

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici

3
Sottoscrivi